Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alabama Crs
Birmingham, Alabama, United States
- Ucla Care Center Crs
Los Angeles, California, United States
- University of Southern California Crs
Los Angeles, California, United States
- Ucsd Antiviral Research Center Crs
San Diego, California, United States
- Ucsf Hiv/aids Crs
San Francisco, California, United States
- Harbor-Ucla Crs
Torrance, California, United States
- University of Colorado Hospital Crs
Aurora, Colorado, United States
- Northwestern University Crs
Chicago, Illinois, United States
- Johns Hopkins University Crs
Baltimore, Maryland, United States
- Brigham and Women'S Hospital Therapeutics Clinical Research Site (bwh Tcrs) Crs
Boston, Massachusetts, United States
- Washington University Therapeutics (wt) Crs
St Louis, Missouri, United States
- New Jersey Medical School Clinical Research Center Crs
Newark, New Jersey, United States
- Chapel Hill Crs
Chapel Hill, North Carolina, United States
- Greensboro Crs
Greensboro, North Carolina, United States
- Cincinnati Clinical Research Site
Cincinnati, Ohio, United States
- Case Clinical Research Site
Cleveland, Ohio, United States
- Ohio State University Crs
Columbus, Ohio, United States
- Penn Therapeutics, Crs
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Crs
Pittsburgh, Pennsylvania, United States
- the Miriam Hospital Clinical Research Site (tmh Crs) Crs
Providence, Rhode Island, United States
- Vanderbilt Therapeutics (vt) Crs
Nashville, Tennessee, United States
- Houston Aids Research Team Crs
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2014
- Primary completion
- 8 Dec 2016
- Completion
- 8 Dec 2016
- Last update posted
- 1 Nov 2021
- Registered enrollment
- 176
- Registry id
- NCT01949116
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.